Use of acute phase proteins for the clinical assessment and management of canine leishmaniosis: general recommendationsJ. M. Castro Cerón, Silvia Martı́nez-Subiela, Luis Pardo-Marín et al.|BMC Veterinary Research|2018Cited by 43
Identification of novel biomarkers for treatment monitoring in canine leishmaniosis by high-resolution quantitative proteomic analysisSilvia Martı́nez-Subiela, Zeki Yılmaz, Anita Horvatić et al.|Veterinary Immunology and Immunopathology|2017Cited by 41
Changes in serum biomarkers of oxidative stress after treatment for canine leishmaniosis in sick dogsCamila Peres Rubio, J. M. Castro Cerón, Silvia Martı́nez-Subiela et al.|Comparative Immunology Microbiology and Infectious Diseases|2016Cited by 30
Evaluation of various biomarkers for kidney monitoring during canine leishmaniosis treatmentLuis Pardo-Marín, J. M. Castro Cerón, Asta Tvarijonaviciute et al.|BMC Veterinary Research|2016Cited by 28
Serum apolipoprotein-A1 as a possible biomarker for monitoring treatment of canine leishmaniosisDamián Escribano, Silvia Martı́nez-Subiela, Asta Tvarijonaviciute et al.|Comparative Immunology Microbiology and Infectious Diseases|2016Cited by 25